9月8日 - ** 诺华印度公司（NOIN.BO）股价一度大涨12.9%，创下1,850.95卢比的历史新高
** NOIN 与诺华医疗保健公司签署独家推广和分销协议，将在印度推广其视网膜产品组合
** 根据协议，诺华印度将独家在印度分销Accentrix和Pagenax，标志着其进军眼科领域，并将向诺华健康护理公司（NHPL）支付1亿卢比的预付款(105万美元)
** 周一，诺华印度公司表示，将以约125亿卢比的价格从辉瑞公司 PFE.N 收购Minipress品牌及相关知识产权
** 辉瑞印度公司 PFIZ.NS 将停止销售“Minipress XL”，并从母公司获得1390万美元；该药物用于治疗高血压和良性前列腺增生（BPH）相关的尿路症状
** 今年迄今，诺华印度公司股价上涨约137%
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.